Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy
Clinical trial NCT05847920 · TERMINATED
Trial details
- NCT number
- NCT05847920
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-04
- Primary completion
- 2025-01-20
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.